David Spencer
Overview
Explore the profile of David Spencer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
1693
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Polonis K, Blommel J, Hughes A, Spencer D, Thompson J, Schroeder M
Clin Chem
. 2025 Jan;
71(1):97-108.
PMID: 39749506
Background: Massively parallel sequencing (MPS) of nucleic acids has been a transformative technology for basic and applied genomic science, increasing efficiencies and decreasing costs to enable studies of unprecedented scope...
2.
Sankar C, Meyer J, Schonfeldt M, Gunter H, Dawood H, Sekiti V, et al.
Vaccine
. 2024 Dec;
46():126535.
PMID: 39645433
Background: Surveillance systems for monitoring and reporting adverse events following immunisation (AEFI) and adverse events of special interest (AESI) are vital in understanding safety profiles of post-marketed vaccines. Evaluation of...
3.
Pitchai F, Tanner E, Khetan N, Vasen G, Levrel C, Kumar A, et al.
Science
. 2024 Aug;
385(6709):eadn5866.
PMID: 39116226
Antiviral therapies with reduced frequencies of administration and high barriers to resistance remain a major goal. For HIV, theories have proposed that viral-deletion variants, which conditionally replicate with a basic...
4.
Osarogiagbon R, Ray M, Fehnel C, Akinbobola O, Saulsberry A, Dortch K, et al.
Ann Thorac Surg
. 2023 Sep;
117(3):576-584.
PMID: 37678613
Background: Despite its prognostic importance, poor pathologic nodal staging of lung cancer prevails. We evaluated the impact of 2 interventions to improve pathologic nodal staging. Methods: We implemented a lymph...
5.
Gervais A, Dirksen E, Pohl T, Bechtold-Peters K, Burkitt W, DAlessio V, et al.
Eur J Pharm Biopharm
. 2023 Aug;
191:57-67.
PMID: 37582411
Multi-attribute methods employing mass spectrometry are applied throughout the biopharmaceutical industry for product and process characterization purposes but are not yet widely accepted as a method for batch release and...
6.
Aldoss I, Tizro P, Bedi D, Mangan J, Clark M, Spencer D, et al.
Haematologica
. 2023 Jul;
108(12):3511-3516.
PMID: 37470155
No abstract available.
7.
Pohl T, Gervais A, Dirksen E, DAlessio V, Bechtold-Peters K, Burkitt W, et al.
Eur J Pharm Biopharm
. 2023 May;
188:231-242.
PMID: 37146738
Multi-attribute methods employing mass spectrometry are applied throughout the biopharmaceutical industry for product and process characterization purposes but are not yet widely accepted as a method for batch release and...
8.
Basma J, Dacus M, Kumar R, Spencer D, Arnautovic K
Oper Neurosurg (Hagerstown)
. 2023 Jan;
24(2):e75-e84.
PMID: 36637310
Background: Questions remain regarding optic nerve (ON) physiology, mechanical compliance, and microvasculature, particularly surgical outcomes and atypical visual field defects associated with sellar/parasellar pathology (eg, tumors and aneurysms). Objective: To...
9.
Wong P, Ng B, Mitchell J, Han J, Lam C, Spencer D, et al.
Intern Med J
. 2022 Jun;
53(8):1450-1457.
PMID: 35670212
Background: Gout is a common chronic inflammatory disorder due to monosodium urate deposition, which results in severe inflammatory arthritis. It is particularly common in those of Māori or Pacific Islander...
10.
Vo A, Ambady P, Spencer D
Epilepsy Behav Rep
. 2022 Feb;
18:100526.
PMID: 35198955
Compared to high grade gliomas, low grade gliomas such as oligodendrogliomas are often more epileptogenic. Epilepsy develops in 70-90% of patients with oligodendrogliomas and 40% of these are resistant to...